Among these eligible studies, thirteen studies were clinical trials reporting the ERCC1 expression and cervix cancer, three studies (33–35) were clinical studies reporting the ERCC1 polymorphism and cervix cancer, and three experimental studies (21, 36, 37) reporting the molecular roles of ERCC1 in cervix cancer. The gene discussed is ERCC1; the disease is cervical cancer.